Host cells reduce glucose uptake and glycogen deposition in response to hepatic insulin gene therapy.
about
Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice.Combinatorial insulin secretion dynamics of recombinant hepatic and enteroendocrine cells.NO-1886 ameliorates glycogen metabolism in insulin-resistant HepG2 cells by GSK-3β signalling.
P2860
Host cells reduce glucose uptake and glycogen deposition in response to hepatic insulin gene therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Host cells reduce glucose upta ...... hepatic insulin gene therapy.
@en
Host cells reduce glucose upta ...... hepatic insulin gene therapy.
@nl
type
label
Host cells reduce glucose upta ...... hepatic insulin gene therapy.
@en
Host cells reduce glucose upta ...... hepatic insulin gene therapy.
@nl
prefLabel
Host cells reduce glucose upta ...... hepatic insulin gene therapy.
@en
Host cells reduce glucose upta ...... hepatic insulin gene therapy.
@nl
P2093
P2860
P356
P1476
Host cells reduce glucose upta ...... hepatic insulin gene therapy.
@en
P2093
Adam G Campbell
Darin E Olson
Jin-an Zhang
Marty H Porter
Peter M Thulé
Sara A Paveglio
P2860
P304
P356
10.2310/6650.2005.00404
P577
2005-05-01T00:00:00Z